Introduction to Translational Research
There are many innovative therapeutic approaches, but very few of them find their way to bedside - especially when these are developments from academic research.
Prof. Dr. Sven Stegemann, managing director of the new translational research centre Leibniz Joint Lab "first in Translation" in Aachen, explains how promising therapeutic innovations can be brought into clinical application in the future.
In his Healthtech Lecture at Leibniz Health Technologies (lecture in German, presentation slides in English), he explains the basics of the new field of translational research and how he and the team will support clinicians and researchers in the translational process in the future:
- The importance of academic institutions in healthcare innovation (3:26 min)
- Terminology (4:59 min)
- Translational Research (9:04 min)
- History of the Leibniz Joint Lab „first in Translation“ (fiT) (24:54 min)
- Leibniz Joint Lab fiT integrated framework (27:58 min)
- Leibniz Joint Lab fiT network value proposition (47:28 min)
- Facts of the Leibniz Joint Lab fiT (50:32 min)
- Conclusions and contact (52:36 min)
- Q&A (56:56 min)
Interested clinicians and researchers are welcome to get in touch with Sven Stegemann.
The Uniklinik der RWTH Aachen (UKA) and the DWI - Leibniz Institute for Interactive Materials (DWI) at Campus Melaten have joined forces and bundled their expertise, which now covers the entire process of translational research with the Center for Translation and Clinical Research (CTC-A) and the Leibniz Joint Lab "first in Translation".
With the help of funds from the structural programme "Operational Programme of North Rhine-Westphalia for the Promotion of Investments in Growth and Employment from the European Regional Development Fund" (OP EFRE NRW), laboratory, training and office space is being created on 5 floors in the Leibniz Joint Lab, where we are developing test samples of new medical products together with the medical faculty of the RWTH Aachen University. The building is scheduled to go into operation in mid-2023.